483
Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. – FDA 483
Record Details
The FDA inspected Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd. in Changzhou, China, an API manufacturer. The inspection revealed significant deficiencies in control record management, specifically regarding logbook reconciliation and the lack of hard-bounded, numbered pages. Additionally, the firm's quality assurance unit failed to conduct comprehensive reviews of electronic data and audit trails for analytical results.
- Product type
- drugs
View Company Profile
ID · 88731eb4-5ab6-4b2a-b83c-bc408946c100
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.